These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35469973)

  • 21. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
    Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Barber N; Wilinska ME; Boughton C; Musolino G; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Diabetes Care; 2019 Apr; 42(4):594-600. PubMed ID: 30692242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents.
    Cobry EC; Hamburger E; Jaser SS
    Diabetes Technol Ther; 2020 Nov; 22(11):794-800. PubMed ID: 32212971
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of Options to "Boost" (Enhancing Insulin Infusion Rates) and "Ease-Off" (Reducing Insulin Infusion Rates) in CamAPS FX Hybrid Closed-Loop System: A Real-World Analysis.
    Royston C; Bergford S; Calhoun P; Sibayan J; Ruan Y; Boughton C; Wilinska ME; Hovorka R
    Diabetes Technol Ther; 2024 Sep; ():. PubMed ID: 39146468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 26. Challenges of optimizing glycaemic control in children with Type 1 diabetes: a qualitative study of parents' experiences and views.
    Lawton J; Waugh N; Barnard KD; Noyes K; Harden J; Stephen J; McDowell J; Rankin D
    Diabet Med; 2015 Aug; 32(8):1063-70. PubMed ID: 25472898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of using a closed-loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents.
    Lawton J; Blackburn M; Rankin D; Allen J; Campbell F; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Hovorka R;
    Diabet Med; 2019 Jun; 36(6):753-760. PubMed ID: 30575114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of remote monitoring with continuous glucose monitoring in young children with Type 1 diabetes: the parents' perspective.
    Burckhardt MA; Fried L; Bebbington K; Hancock M; Nicholas JA; Roberts A; Abraham MB; Davis EA; Jones TW
    Diabet Med; 2019 Nov; 36(11):1453-1459. PubMed ID: 31257642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
    Tauschmann M; Allen JM; Wilinska ME; Thabit H; Stewart Z; Cheng P; Kollman C; Acerini CL; Dunger DB; Hovorka R
    Diabetes Care; 2016 Jul; 39(7):1168-74. PubMed ID: 26740634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes.
    Farrington C; Stewart ZA; Barnard K; Hovorka R; Murphy HR
    Diabet Med; 2017 Oct; 34(10):1461-1469. PubMed ID: 28631849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England.
    Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2020 May; 22(5):404-410. PubMed ID: 31913061
    [No Abstract]   [Full Text] [Related]  

  • 34. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.
    Hendrieckx C; Poole LA; Sharifi A; Jayawardene D; Loh MM; Horsburgh JC; Bach LA; Colman PG; Kumareswaran K; Jenkins AJ; MacIsaac RJ; Ward GM; Grosman B; Roy A; O'Neal DN; Speight J
    Diabetes Technol Ther; 2017 Jul; 19(7):410-416. PubMed ID: 28537437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health professionals' views about who would benefit from using a closed-loop system: a qualitative study.
    Lawton J; Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Randell T; Besser REJ; Trevelyan N; Hovorka R;
    Diabet Med; 2020 Jun; 37(6):1030-1037. PubMed ID: 31989684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closed-loop in children with type 1 diabetes: specific challenges.
    Elleri D; Allen JM; Dunger DB; Hovorkea R
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S131-5. PubMed ID: 21864745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
    Gildersleeve R; Riggs SL; Cherñavvsky DR; Breton MD; DeBoer MD
    Diabetes Technol Ther; 2017 Nov; 19(11):660-674. PubMed ID: 28854339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
    Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safe and effective use of a hybrid closed-loop system from diagnosis in children under 18 months with type 1 diabetes.
    Tseretopoulou X; Viswanath V; Hartnell S; Ware J; Thankamony A; Webb EA; Hysted H; Ashford J; Hendriks E; Teoh Y; Williams RM
    Pediatr Diabetes; 2022 Feb; 23(1):90-97. PubMed ID: 34820972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.